Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.90% | -0.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.90% | -0.29% | |||
| Cost of Revenue | 10.75% | -3.18% | |||
| Gross Profit | 4.96% | 6.50% | |||
| SG&A Expenses | 4.17% | -38.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -26.20% | -152.03% | |||
| Total Operating Expenses | 8.80% | -2.12% | |||
| Operating Income | 10.63% | 45.20% | |||
| Income Before Tax | 25.01% | 132.33% | |||
| Income Tax Expenses | 59.04% | -79.42% | |||
| Earnings from Continuing Operations | 13.58% | 194.56% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.58% | 194.56% | |||
| EBIT | 10.63% | 45.20% | |||
| EBITDA | 7.29% | 115.66% | |||
| EPS Basic | 13.76% | 194.78% | |||
| Normalized Basic EPS | 14.00% | 122.22% | |||
| EPS Diluted | 13.76% | 194.78% | |||
| Normalized Diluted EPS | 14.00% | 122.22% | |||
| Average Basic Shares Outstanding | 0.05% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.05% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||